|
Video: What is a Stock Split?
|
|
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Co.'s pipeline includes product candidates that utilize its understanding of the tumor microenvironment, including both angiogenesis-targeted agents and immune-oncology focused agents. These product candidates are designed to support critical components required for an anti-tumor response to cancer. These include modulation of the microvasculature via angiogenesis-targeted agents, and induction of an immune response via activators on effector cells in the tumor microenvironment. According to our Compass Therapeutics stock split history records, Compass Therapeutics has had 0 splits. | |
|
Compass Therapeutics (CMPX) has 0 splits in our Compass Therapeutics stock split history database.
Looking at the Compass Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Compass Therapeutics shares, starting with a $10,000 purchase of CMPX, presented on a split-history-adjusted basis factoring in the complete Compass Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/06/2021 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$8.50 |
|
End price/share: |
$1.70 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-80.00% |
|
Average Annual Total Return: |
-40.73% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,000.22 |
|
Years: |
3.08 |
|
|
|
|
|